Luca Scavo - Jun 1, 2021 Form 4 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
CFO
Signature
/s/ Daniel S. Char, Attorney-in-Fact for Luca Scavo
Stock symbol
EVLO
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4
Date filed
6/3/2021, 04:49 PM
Next filing
Jan 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +300K $0.00 300K Jun 1, 2021 Common Stock 300K $14.24 Direct F1
transaction EVLO Restricted Stock Units Award $0 +4.55K $0.00 4.55K Jun 1, 2021 Common Stock 4.55K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of underlying shares will vest on 1st anniversary of employment commencement date (i.e., June 1, 2022), and remaining 75% of underlying shares will vest in 36 substantially equal monthly installments thereafter
F2 These options will vest 100% on 3rd anniversary of employment commencement date (i.e., June 1, 2024)